Article published Jul 31, 2026. Prices below use latest available snapshots.
Conviction: Medium (was Speculative; Q1 2026 print upgraded it) Status: Research-watch — not held, not yet sized
2026-07-31 tape note: VICR $207.37 (+7.94% vs $192.12), RSI 39.4 (warmed from 33). 7D -1.73% (moderated from -10.52%), 30D -40.79% (moderated from -47.62%), 3M -22.73% (moderated from -25.16%). From the 52-week high, the gap is -45.81% (narrowed from -49.79%). Per the tape: trend "weak-down", regime "pullback", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-07-31 close). 2026-08-08 tape note: VICR $221.20 (+6.67% vs $207.37), RSI 44.3 (warmed from 39.4). 7D +6.67% (turned positive from -1.73%), 30D -15.94% (moderated from -40.79%), 3M -13.75% (moderated from -22.73%). From the 52-week high, the gap is -42.75% (narrowed from -45.81%). Per the tape: trend "weak-down", regime "pullback", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-07 close). 2026-08-14 tape note: VICR $234.74 (+6.12% vs $221.20), RSI 50.9 (warmed from 44.3). 7D +6.12% (moderated from +6.67%), 30D -9.78% (moderated from -15.94%), 3M -14.23% (roughly flat from -13.75%). From the 52-week high, the gap is -40.77% (narrowed from -42.75%). Per the tape: trend "weak-down", regime "pullback", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-14 close).
Editorial Note
VICR at $272.05 RSI 43.3 has extended the pullback flagged at the 06/16 refresh into a much sharper digestion. At 06/16, VICR was at $320.46 RSI 58, +6.0% above SMA20, described as "pulled back modestly" from the May 29 peak. Since then price has fallen further: -9.07% 7D, -8.73% 30D, RSI has cooled from 58 to 43.3 (neutral-to-soft, no longer "neutral-positive"). Price is now -13.9% below SMA20 ($315.94) and -9.1% below SMA50 ($299.19) — a real short-term breakdown — but remains +56.6% above SMA200 ($173.73), and the summary now shows a golden cross confirmed / death cross false, i.e. the long-term structure is still intact and improving even as the short-term tape has broken down. From 52wk high has widened to -28.9% (vs -11.45% at 06/16). +46.09% 3M still shows the multi-month re-rate is largely intact. No new fundamentals have been re-researched this cycle — the Q2 2026 print flagged as "the next anchor" at 06/16 has not yet been confirmed in this data; treat the pullback as a technical digestion pending that print, not a fundamental reversal.
Tape-vs-thesis note (2026-07-11): The 06/16 Entry Approach explicitly set "Add on: Backlog confirmation at Q2 print or pullback with RSI <50" as a condition. RSI is now 43.3, i.e. the RSI<50 pullback leg of that condition has been met on price alone, without the Q2 backlog confirmation. Per the entry strategy as written, this is a partial trigger, not a full one — the Q2 print is still the gating event before adding, and no earnings data yet confirms whether backlog held. Flag for human review before treating this dip as an entry.
Tape-vs-thesis note (2026-07-17): The pullback has deepened further. VICR $237.62, RSI 38.7 (down from 43.3), now -20.7% below SMA20 ($299.69) and -20.2% below SMA50 ($297.86) — a much sharper breakdown than two weeks ago. 7D -12.66%, 30D -28.29% (deepened from -8.73%), 3M +5.7% (moderated sharply from +46.09%). -37.9% from 52wk high (widened from -28.9%). Still +33.0% above SMA200 — long-term structure intact. Q2-26 earnings (~Jul 2026) is still the gating catalyst and has not yet printed in this data. No new fundamentals re-researched; the RSI<50 condition remains met but the backlog confirmation is still pending.
Tape-vs-thesis note (2026-07-25, Friday 2026-07-24 close): The pullback has continued. VICR $211.01, RSI 36.0 (down from 38.7), now -22.0% below SMA20 ($270.62) and -27.7% below SMA50 ($291.89) — a wider SMA50 gap than two weeks ago, with the SMA20 gap roughly similar. 7D -11.2% (roughly in line with -12.66%), 30D -34.53% (deepened from -28.29%), 3M -22.86% (turned negative, down from +5.7%). -39.53% from 52wk high (widened from -37.9%). Still +15.3% above SMA200 — a narrower cushion than +33.0% at 07/17, but golden cross remains confirmed, death cross false — long-term structure intact. Q2-26 earnings (~Jul 2026) is still the gating catalyst and has not yet printed in this data. Price ($211.01) is now below the original $215-$245 entry zone. No new fundamentals re-researched; the RSI<50 condition remains met but backlog confirmation is still pending.
Tape-vs-thesis note (2026-07-28): The pullback has deepened sharply. VICR $192.12 (-9.0% vs $211.01), RSI 33 (down from 36.0), now -27.1% below SMA20 ($263.65) and -33.6% below SMA50 ($289.46) — both gaps widened materially. 7D -10.52% (roughly in line with -11.2%), 30D -47.62% (deepened sharply from -34.53%), 3M -25.16% (deepened from -22.86%). -49.79% from 52wk high — a new deepest drawdown, widened from -39.53%. The SMA200 cushion has narrowed sharply to +4.6% (from +15.3%) — golden cross remains confirmed, death cross false, but the long-term structure is now much closer to a test. Q2-26 earnings is still the gating catalyst and has not yet printed in this data. Price ($192.12) remains below the original $215-$245 entry zone and is now roughly 7.9% above the $178 stop-loss level. No new fundamentals re-researched; the RSI<50 condition remains met but backlog confirmation is still pending — human review still required before treating this as an entry.
The Story Right Now
A cohort the watchlists don't track yet — MPWR, AOSL, VICR, IFNNY, NVTS, POWI, BESI, MRAAY — has emerged as the cleanest "catch up" trade on the board. VICR is the philosophically loaded one in that group. NuttyCLD's framing is exactly right: Vicor is the original home of factorized power architecture, the conceptual ancestor of every Vertical Power Delivery slide deck shipping out of Infineon and Delta right now. For a decade VICR was the archetype of "technically right, commercially under-rewarded." The stock spent 2007-2022 in cycles of "this time is different" that almost always wasn't.
What's different this time is that the order book finally caught up to the press releases. Q4 2025 (reported Feb 19): backlog $176.9M (+13.8% YoY, +15.8% sequentially), book-to-bill >1.2x, Gen 5 VPD into production with a lead customer, and management framing 2026 as a "record year for product revenues." Three months later, Q1 2026 (reported April 21): revenue $113M (+20.2% YoY), backlog $300.6M — an additional 70% jump in a single quarter — book-to-bill over 2.0, gross margin 55.2%, FY 2026 guide ~$570M. Roth Capital raised PT to $245 the same day. That is what an inflection looks like, and the tape knows: VICR is now at $320.46, +63% in 3 months.
The wrinkle the bullish narrative is going to have to absorb is the insider activity: $218.8M net selling, zero buys on the leading-indicators rolling window. That's substantial, and it's not noise. Davies (the VP whose $200-$400/XPU framing is the thesis) himself sold $1.45M earlier in the cycle. This doesn't break the thesis — at this kind of stock-price move, holders trimming is rational — but it does mean the float has more circulating ammo to absorb, which usually translates to digestion before the next leg. Pair with the fact that VICR also runs an active ITC patent enforcement campaign (Feb 2025 ITC final determination against Delta, Quanta, Foxconn affiliates; second ITC investigation now instituted on NBM patents; settlement income from Delta + Infineon + Monolithic has been running through the P&L) and you have a story where the legal monetization of factorized power IP is starting to rhyme with the commercial monetization of Gen 5 VPD. Two arrows pointing the same way for the first time in 25 years.
Bottom line: the catalyst is no longer hypothetical. The framing isn't "watch for the curse to crack" — the curse cracked on the April 21 print. The trade now is positioning around the digestion of a name that has already moved a lot, where the 2H 2026 broader Gen 4→Gen 5 transition is the next leg-test, and where bulls have to be willing to underwrite a high-eighties P/E against a track record that includes a lot of head-fakes.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 Weak-down — RSI 39.4, -45.8% from 52wk high |
| Moat | Narrow-to-Wide (factorized power IP + Gen 5 VPD socket; ITC enforcement turns IP into a toll booth) |
| Key insight | Q1 2026 backlog jumped from $176.9M to $300.6M in one quarter (+70%). Book-to-bill >2.0x. The thesis stopped being conditional. |
Action Matrix
| Action | Level | Why |
|---|---|---|
| Current | RSI 39.4, weak-down | pullback, -45.8% from 52wk high |
| Entry Zone | $215 - $245 | Original zone — price ($192.12) is now well below it |
| Stop-Loss | $178 (-25%) | Price is now only ~7.9% above this level — closest approach yet. Below SMA200; thesis-killer = backlog reversal at Q2 print |
| Target | $349 (+47% from current) | Conservative on the high-end analyst consensus; bull-case beyond $400 if Gen 4→5 broader transition prints clean |
Price Data
| Metric | Value |
|---|---|
| Price | $234.74 |
| RSI (14) | 50.9 |
| SMA20 | $215.35 (+9.0%) |
| SMA50 | $265.64 (-11.6%) |
| SMA200 | $194.15 (+20.9%) |
| Trend | weak-down |
| Golden cross | Yes |
| Regime | pullback |
| 7D | +6.12% |
| 30D | -9.78% |
| 3M | -14.23% |
| From 52wk High | -40.77% |
Company Overview
One-Liner
Vicor designs and manufactures modular power converters and Vertical Power Delivery (VPD) modules that sit between 800V data center infrastructure and the ~0.7V transistor — the "last few centimeters" of AI power delivery, where Blackwell B200 needs ~1,500A and Vera Rubin pushes ~2,875A.
Business Model
| Question | Answer |
|---|---|
| What they sell | Modular power converters, current multiplier modules, VPD modules (Gen 4 → Gen 5), bus converter modules, plus a growing royalty/license stream from IP enforcement |
| Who pays | OEMs, ODMs, hyperscalers, defense / aerospace, industrial. Lead AI customer (publicly described as wafer-scale AI engine maker — Cerebras-like profile) on Gen 5 VPD ramp Q1 2026 |
| Revenue model | Product (~$92.7M Q4'25 / $107.3M Q1'26 advanced+brick split) + royalties (settlement and license income from Delta, Infineon, Monolithic) |
| How sticky | High. Power module sockets are designed-in at the package level; ITC exclusion orders + patent licensing build a moat around the architecture itself |
Key Segments (Q1 2026)
| Segment | Q1 2026 Revenue | % of Total | Notes |
|---|---|---|---|
| Advanced Products (VPD, current multipliers, ChiP) | $64.9M | 57.5% | The AI-leveraged segment; this is the Gen 5 VPD line |
| Brick Products (legacy DC-DC, industrial/defense) | $48.0M | 42.5% | Mature but recovering — bricks +7.7% sequentially |
| Royalty / License | (rolled up in revenue) | minor but rising | Step-function increases on settlements; $200-400/XPU framing implies royalty leverage on broader ecosystem |
Geographic Mix
Global; majority US-headquartered manufacturing (Andover, MA fab). Heavily diversified by geography because hyperscaler customers ship to global data center footprints.
Competitive Analysis
Industry Position
| Question | Answer |
|---|---|
| Market share | Single-digit unit share in VRM/PMIC overall; philosophical share of factorized architecture concept = 100% (originator) |
| Market size (TAM) | If Phil Davies $200-400/XPU framing is real and AI XPU shipments are ~10M-20M/year by 2027 → $2-8B/year addressable for just the per-XPU power module slice. Morgan Stanley estimates Kyber rack power-solution value rises >10x vs GB200. |
| Growth rate | VICR product revenue: +20.2% YoY Q1 2026; backlog +70% sequentially. The market is growing faster than VICR can capture, which is the opportunity AND the risk |
| Key competitors | Infineon (IFNNY) + Delta (2308.TW) — the Blackwell winners; MPWR (Vera Rubin VRM ~70% share at +60% ASP per sell-side); AOSL (OpenVReg co-leader, GB300); POWI (high-voltage GaN topology); NVTS (GaN); ADI / TXN / ON (mainstream PMIC) |
| Position | Niche-philosophical-leader, commercial under-share, IP enforcement teeth |
Competitive Moat
| Moat Type | Present? | Evidence |
|---|---|---|
| Network effects | 🔴 | Power modules don't have network effects |
| Switching costs | 🟢 | Designed-in at the package level; respinning a board to remove VPD is non-trivial. Reference design footprint is the moat |
| Cost advantages | 🟡 | Vertical integration, in-house Andover manufacturing, but lacks Infineon-scale wafer leverage |
| Intangible assets | 🟢🟢 | Factorized Power Architecture patents (US 9,166,481, 9,516,761, 10,199,950); ITC exclusion orders against Delta, Quanta, Foxconn affiliates; PTAB denied IPR (validity confirmed); second ITC investigation on NBM patents instituted Q4 2025 |
| Efficient scale | 🔴 | Sub-scale relative to Infineon, MPS, Delta. Always has been. |
Moat Assessment
Moat Width: Narrow → Widening (pivoting from "good IP, no leverage" to "good IP, ITC-enforced toll booth, plus first-customer Gen 5 socket") Moat Trend: Widening
Summary:
Vicor's moat is the patent estate on factorized power and the architecture's structural fit with VPD. Historically that moat was inert — they couldn't translate IP into commercial scale. The 2024-2026 pivot is to enforce the IP via ITC while also riding Gen 5 VPD into production sockets. Both arrows are pointing the same direction for the first time in the company's history. The bear case isn't that the moat doesn't exist — it's that the moat keeps generating settlement payments rather than designed-in production share.
Management Assessment
Leadership
| Role | Name | Since | Background | Notes |
|---|---|---|---|---|
| Chairman / President / CEO | Dr. Patrizio Vinciarelli | 1981 (founder) | Italian-born physicist, Harvard PhD, fellow at CERN (1973-76) and Princeton IAS (1977-80). 2019 IEEE William E. Newell Power Electronics Award. | The technical visionary. Famously commercial-allergic — the company's "right-but-unrewarded" arc is closely tied to his preference for IP and architectural elegance over lead-time / supply-chain discipline |
| VP Global Sales & Marketing | Phil Davies | (long-tenure) | Operational execution, the public revenue voice on Q4 2025 / Q1 2026 calls | The new revenue voice. $200-$400/XPU framing came from him. Sold $1.45M of stock recently — context-rational, but material to the insider-distribution picture |
Founder Involvement
| Question | Answer |
|---|---|
| Founder-led? | Yes — 45 years and counting |
| Founder ownership | High (Vinciarelli is a long-time significant holder; specific % varies by filing) |
| Skin in the game | Very high. Concentration risk: the company's strategic gravity is one person |
Capital Allocation
| Metric | Track Record |
|---|---|
| M&A discipline | Conservative (almost no M&A — organic only) |
| Buyback timing | Mixed — VICR has bought back stock at lower prices, less so during runs |
| R&D investment | High — R&D ~$80M annualized at ~19% of revenue (Q1'26 R&D $19.4M / revenue $113M) |
| Debt management | Conservative — $0 long-term debt, $0 net debt, debt-to-equity 0 |
Red Flags
- ⚠️ Insider distribution: $218.8M net sold over leading-indicators rolling window, zero buys. Big.
- ⚠️ Founder concentration risk — Vinciarelli is 76+ years old; succession is unspoken
- ⚠️ Historical cadence of "this time is different" press releases that didn't land. The market has been burned.
- ✅ No related-party games, no aggressive accounting, balance sheet is pristine
Financials
Key Quarterly Metrics
| Metric | Q1 2026 | Q4 2025 | Q1 2025 | YoY Trend |
|---|---|---|---|---|
| Revenue | $113.0M | $107.3M | $94.0M | +20.2% YoY 📈 |
| Gross Margin | 55.2% | 55.4% | 47.2% | +800 bps YoY 📈 |
| Operating Margin | (Q4 14.6%) | 14.6% | -0.2% | flipped from negative 📈 |
| FCF Margin | 9.5% see note† | — | low | recovering 📈 |
| Backlog | $300.6M | $176.9M | ~$155M | +94% YoY 📈📈 |
| Book-to-Bill | >2.0x | >1.2x | ~1.0x | inflection-level |
Quality Checks
| Check | Status | Notes |
|---|---|---|
| FCF positive? | 🟢 | Q4 2025 FCF $10.2M †Q4 2025 operating cash flow +$15.7M; the $10.2M was OCF plus total investing outflow (−$5.5M), not OCF − capex — capex is undisclosed in the cache, so the true FCF line is unavailable (corrected 2026-08-03). Cash generation itself is real |
| Profitable? | 🟢 | Net income $46.5M Q4, sustained Q1 |
| Debt manageable? | 🟢🟢 | Zero long-term debt, $785M total assets / $74M total liabilities |
| Cash runway | Indefinite | The balance sheet is ~$712M of equity, near-zero leverage |
Leading Indicators
| Indicator | Value | Signal |
|---|---|---|
| Revenue Acceleration | +18.85% | 🟡 Neutral (was bigger; Q4 normalized) |
| YoY Growth | +11.5% (trailing) → +20.2% (Q1'26 actual) | 🟢 Accelerating |
| Earnings Beat Rate | 100% | 🟢🟢 Strong |
| Insider Trading | -$218.8M net | 🔴 Bearish (size-warning) |
| Composite | 0.1 | 🟡 Neutral overall, but signal is reshuffling |
Valuation
Current Multiples
| Metric | Current | 5Y Range | Industry Avg | Read |
|---|---|---|---|---|
| P/E (TTM) | ~~~83~~ ~72 (rescaled 2026-08-14: the 2026-08-03 correction fixed the net-income basis but never re-priced past its $272.05 basis; rescaled by the $234.74/$272.05 price ratio on the same TTM-earnings basis, no fresh EPS pull this cycle) | wide swings | ~25 (semis avg) | Premium — priced for AI inflection |
| P/S (TTM) | ~~~22~~ ~19 (rescaled 2026-08-14, same basis) | 8-30 | ~6-8 | Premium |
| EV/Revenue | ~~~21~~ ~18 (rescaled 2026-08-14, same basis) | 8-28 | ~5-7 | Premium |
| Market Cap | $12.2B ~$10.5B (rescaled 2026-08-14 at $234.74 on the same share count; not independently refetched) | — | — | Vs ~$50M FY 2024 net income Vs $136.7M trailing-12-month net income (filed quarters summed; FY2024 itself was just $6.1M) (corrected 2026-08-03: the ~$50M matched no filed period — the adjacent P/E ~83-89x line was always consistent with the TTM figure) — multiple expansion is still doing most of the work |
Analyst Price Targets (post Q1 2026)
| Source | Target | Implied | Notes |
|---|---|---|---|
| Roth Capital (Apr 21) | $245 | below current | Buy reiterated, raised from $225 — most influential post-print call; price has since run above this |
| Average (per public.com) | $208.75 | below current | Range $180-$230 |
| WallStreetZen 1Y | $132.50 | below current | The bear pricing — assumes mean reversion to pre-AI multiple |
| Bull case (sell-side max) | $245-$300+ | at/below current | Davies $200-400/XPU × 10M+ XPUs/year fully rerated |
Fair Value Frame
| Method | Fair Value | Read |
|---|---|---|
| 2026 EPS consensus $2.69 × 60x P/E (AI premium) | ~$160 | Bear-rational |
| 2026 EPS $2.69 × 80x P/E (current premium) | ~$215 | Prior digestion zone — now below market |
| 2026 EPS $2.69 × 100x P/E (full thesis) | ~$270 | Near current price |
| FY 2026 revenue $570M × 25x EV/Sales | ~$315 | Above current price |
My fair value: $215-$270 range — current price at $272.05 is now near the top of that original range rather than above it (was above at 06/16's $320.46). The multiple has compressed somewhat with the pullback. Human review needed at Q2 print.
Bull Case
Why This Could Work (5 Reasons)
The order book is the proof. Backlog went $155M → $176.9M → $300.6M in three quarters. Book-to-bill 1.2x → 2.0x in one quarter. That isn't a press release — it's purchase orders. The "trust the order book" narrative finally has a number that supports it.
Phil Davies put a price tag on the thesis: $200-$400 per XPU. First time analysts have a concrete revenue anchor for the AI opportunity in the company's history. At ~10-20M AI XPUs/year by 2027 and even partial socket-share, that's a $2-8B addressable slice for the per-XPU power module alone.
Gen 5 VPD into production with a lead customer in Q1 2026, broader Gen 4→Gen 5 transition 2H 2026. The lead customer (publicly described as wafer-scale AI engine maker, Cerebras-shaped) is already ramping. Broader hyperscaler/OEM transition is the next leg.
ITC enforcement is a second arrow. Feb 2025 final determination against Delta + Quanta + Foxconn affiliates. Second ITC investigation on NBM patents instituted late 2025. Settlement income from Delta + Infineon + Monolithic is recurring. This converts factorized power IP from "inspiring" to "monetizable through both sales and licensing."
NuttyCLD's framing: "the curse may finally be cracking." External, independent confirmation from a thoughtful analyst that VICR's structural moment has arrived. The full-scan brief picks the same cohort up.
Upside Scenario
| If This Happens | Stock Could |
|---|---|
| Q2 2026 backlog holds $300M+ and book-to-bill stays >1.5x | $310-340 (Roth target +) |
| Hyperscaler #2 publicly designs Gen 5 VPD into 2H 2026 platform | $380-450 |
| ITC second investigation = additional settlement step-up | +$15-40 standalone catalyst |
| NVIDIA reference design includes Vicor at any layer | $500+ |
Bear Case
What Could Go Wrong (5 Risks)
25 years of "almost." This is the single most important bear point. The historical pattern is: VICR generates a credible inflection, the stock doubles, and then commercial execution lags the press releases by two more years. The 2018-2020 cycle did this. The 2007-2009 cycle did this. Pattern recognition is not the same as fundamentals, but it's why the float is anxious.
- Probability: Medium. It's literally what's happened multiple times before.
Insider distribution is heavy. -$218.8M net, zero buys. Phil Davies (the revenue-voice executive) sold $1.45M. At $320 with RSI 58 and a 6x in 12 months, insiders selling is rational; the size of the selling means the float keeps absorbing supply.
- Probability: High that this caps near-term upside; Low that it indicates fundamental issue.
Vinciarelli is famously commercial-allergic. The reason VICR was first technically and lost first commercially in Blackwell is partly cultural: Vinciarelli prioritizes architectural elegance and IP purity over lead-time discipline, supply-chain investment, and large-customer service execution. The Razor's Edge short thesis (mid-2025) leaned heavily on this. The pattern could repeat in Gen 5 if VICR can't scale capacity to match the order book.
- Probability: Medium. Q1 2026 print suggests this time is different, but "this time is different" is the historical trap.
The Blackwell winners (Infineon + Delta) aren't going anywhere. They captured Blackwell, they share Vera Rubin with MPS (sell-side projects MPS at ~70% Rubin VRM share), and they have the manufacturing/system-integration discipline VICR has historically lacked. VICR's Gen 5 VPD lead customer is one socket. The broader market has many sockets, and the incumbents are well-positioned.
- Probability: High that VICR stays smaller than the bull case implies.
Valuation has done a lot of work. P/E 83, P/S 22, market cap $12.2B against ~$50M net income trailing. The stock has already repriced for the curse cracking. If Q2 2026 backlog stalls or book-to-bill normalizes back to 1.2x, multiple compression is the path. WallStreetZen's $132 PT is the bear-case-concretized; the Razor's Edge short thesis is even sharper.
- Probability: Medium. Most rallies of this magnitude digest at least 25-30%. This is what the current -8.73% 30D / -28.9% off-highs pullback looks like starting to play out — see tape-vs-thesis note above.
Thesis Killers
- Q2 2026 backlog flat or down sequentially (<$300M)
- Book-to-bill drops below 1.0x
- Lead customer Gen 5 VPD ramp delays announced (hint of execution miss)
- Major hyperscaler designs out of factorized architecture in next-gen platform
- ITC enforcement actions get walked back on appeal
Downside Scenario
| If This Happens | Stock Could |
|---|---|
| Q2 disappoints / backlog flat | $190-215 (-43% to -36%) |
| Multiple compresses to 50x P/E without revenue miss | $135-160 (-60% to -52%) |
| Curse-pattern re-asserts (broader Gen 4→5 transition slips) | $100-130 (-70% to -61%) |
Market-Moving News
Historical (What Has Moved This Stock Before)
| Period | Event | Approximate Impact | Pattern Lesson |
|---|---|---|---|
| 2003 | Factorized Power Architecture (FPA) launch | Multi-quarter rally | Conceptual leadership doesn't = commercial capture |
| 2018-2020 | "AI accelerator power" pitch (Hydra, V-I Chip 1200A ChiP) | 3x then full retrace | Press releases without backlog = repeated head-fake |
| 2021-2023 | Crypto / cooling-off trough | -75% drawdown | Stock is high-beta to AI capex sentiment |
| 2024 | ITC investigation initiated, IP campaign goes public | Step-up reversal | Patent enforcement is a new and durable arrow |
| Feb 2025 | ITC Final Determination — exclusion orders against Delta + Quanta + Foxconn affiliates | +sustained run | First commercial monetization of FPA IP |
| Feb 19, 2026 | Q4 2025 earnings — record $176.9M backlog, Phil Davies $200-400/XPU framing | Strong rally | Inflection narrative gains a number |
| Apr 21, 2026 | Q1 2026 earnings — backlog $300.6M, BTB >2.0x, Roth PT $245 | +20-30% same-week | The moment the curse cracked |
Recent News Drivers
| Date | Headline | Impact | Relevance |
|---|---|---|---|
| 2026-04-21 | VICR Q1 2026: $113M revenue, $300.6M backlog, BTB >2.0x | 🟢🟢 | The print that cracked the curse |
| 2026-04-21 | Roth Capital raises VICR PT to $245 (from $225), reiterates Buy | 🟢 | Sell-side validation |
| 2026-02-19 | VICR Q4 2025: record $176.9M backlog, Davies $200-400/XPU framing | 🟢🟢 | Inflection set up |
| 2025-Q4 | ITC institutes second investigation on NBM patents | 🟢 | IP enforcement second wave |
| 2025-02-13 | ITC Final Determination — exclusion orders against Delta, Quanta, Foxconn affiliates | 🟢 | Patent moat confirmed |
News Patterns
The market overreacts to concept announcements (Hydra, FPA, V-I Chip) and underreacts to backlog announcements until forced. The cleanest signal in VICR's history is order-book inflections; this is one of those.
Related Markets & ETFs
| Symbol | Name | Relationship | Notes |
|---|---|---|---|
| SOXX | iShares Semiconductor ETF | Holds VICR (small weight) | Broad semis exposure |
| SMH | VanEck Semiconductor ETF | Holds VICR (small weight) | Broad semis exposure |
| PSI | Invesco Dynamic Semiconductors | Holds VICR | More targeted semi-cap |
| XSD | SPDR S&P Semiconductor | Equal-weight, holds VICR | Cleaner small/mid-cap semi exposure |
Sector Context
The whole VRM/PMIC/AI-power-delivery cohort is moving (MPWR, AOSL, IFNNY, NVTS, POWI, BESI). VICR is one of the leaders in the cohort by 30D% return, which means part of its move is sector-beta and part is name-specific. The AI power delivery perspective opened today is the framework for tracking the cohort as a unit.
Cross-References (Where This Appears in Our System)
| Location | File | Context |
|---|---|---|
| Articles | inputs/articles/2026-04-19-nuttycld-ai-power-crisis-part-3-last-few-centimeters.md |
Dedicated VICR section — "the curse may finally be cracking" |
| Articles | inputs/articles/2026-03-30-nuttycld-ai-power-crisis-part-1...md (and Parts 2-4) |
Conceptual chain context |
| Perspective | The May 1 ai-power-delivery perspective | VPD layer / Watch For #2 |
| Market Brief | The May 1 full-scan market brief | Coverage gap callout, deep-dive queue, dominant editorial signal |
| Watchlists | (NONE YET) | Coverage gap — VICR not on any watchlist as of 2026-05-01 |
| Holdings | (NONE) | Not held in any paper or real account |
Related Tickers to Monitor
Discovered during research — names that should be tracked alongside VICR.
| Ticker | Why Related | Suggested Placement | Priority | Notes |
|---|---|---|---|---|
| IFNNY | Infineon — primary Blackwell winner with Delta on VPD; the company that beat VICR commercially | ai-power-delivery watchlist (proposed) |
🟢 High | The Blackwell winner VICR should have been |
| MPWR | Monolithic Power Systems — incumbent VRM, projected ~70% Vera Rubin share at +60% ASP | ai-power-delivery watchlist (proposed) |
🟢 High | Cohort leader, first to deep-dive after this |
| AOSL | Alpha and Omega Semi — OpenVReg co-leader, GB300 design wins | ai-power-delivery watchlist (proposed) |
🟢 High | $900M cap small-cap leverage |
| NVTS | Navitas Semiconductor — GaN driver, 800V to 6V GaNFast reference design | ai-power-delivery watchlist (proposed) |
🟡 Med | Earlier-stage |
| POWI | Power Integrations — 1250V/1700V PowiGaN; topology IP play | ai-power-delivery watchlist (proposed) |
🟡 Med | "Owns the topology" angle |
| Delta-2308.TW | Delta Electronics (Taiwan listing) — system anchor, passed Foxconn Jan 2026 | ai-power-delivery watchlist (proposed, ADR if available) |
🟢 High | The non-VICR/IFNNY winner |
| ENPH | Enphase — small-cap power conversion (microinverters); not direct comp but power-conversion peer | consumer-energy cross-list |
🟡 Med | Different end market but relevant peer for valuation framing |
| BESI | BE Semiconductor — hybrid bonding (BSPDN + HBM convergence) | Already in supply-chain-traces |
🟢 High | Already tracked; reinforce |
| MRAAY | Murata — MLCC bottleneck (GB300 = 30,000 MLCCs) | ai-power-delivery watchlist (proposed) |
🟢 High | Different layer, same thesis |
Catalysts & Timing
Upcoming Catalysts
| Date | Event | Impact | Watch For |
|---|---|---|---|
| ~Jul 2026 | Q2 2026 earnings | 🟢🟢 | Backlog ≥$300M sustained, BTB ≥1.5x, Gen 5 ramp commentary |
| 2H 2026 | Broader Gen 4→Gen 5 VPD transition | 🟢🟢 | Public reference of second hyperscaler/OEM design-in |
| ~Oct 2026 | Q3 2026 earnings | 🟢 | Confirmation of Phase 2 transition |
| Ongoing | ITC second investigation on NBM patents | 🟢 | Settlement / exclusion order step-ups |
| 2027 | NVIDIA Feynman platform timing (likely TSMC A16 + SPR) | 🟡 | Whether VICR is on the BoM at any layer |
Key Dates
| Event | Frequency | Next Date |
|---|---|---|
| Earnings | Quarterly | ~Jul 2026 (Q2) |
| Investor / Tech Day | Irregular | TBD |
| ITC enforcement updates | Rolling | Ongoing |
Entry Strategy
Position Sizing
| Conviction | Allocation |
|---|---|
| Speculative | 0% (research only) |
| Low | 1-2% |
| Medium | 3-5% ← my view |
| High | 5-10% |
My conviction: Medium — inflection real, valuation rich, but prior entry zone blown through Target allocation: 2-3% if entered, scaled in
Entry Approach
| Strategy | Details |
|---|---|
| Entry zone | $215 - $245 (original — price ($211.01) is now below it) |
| Starter position | 33% of target on first touch of new digestion level with RSI <65 |
| Add on | Backlog confirmation at Q2 print or pullback with RSI <50 — RSI<50 leg now met (33); Q2 print leg not yet confirmed in this data |
| Full position at | Confirmation of Gen 5 second-customer design-in OR oversold reset |
Technical Levels
| Level | Price | Notes |
|---|---|---|
| Resistance | $315.94 | SMA20 — price now below it (was support at 06/16) |
| Current | $192.12 | RSI 33, -27.1% below SMA20, -33.6% below SMA50, +4.6% above SMA200 |
| Support 1 | $245 | Roth PT, prior breakout — now well above current |
| Support 2 | $215 | Pre-Q1-print breakout shelf — now above current |
| Support 3 | $180 | Heavy if Q2 disappoints — now only ~6.3% below current price |
| Stop / Thesis-killer | $214 | Now above current price |
Sources
- Cash-flow and net-income figures in the 2026-08-03 corrections re-derived from cash-flow-statements and key-financials.
Research Log
| Date | Update |
|---|---|
| 2026-05-01 | Created deep dive after NuttyCLD AI Power Crisis series + 2026-05-01 full-scan brief queued VICR for next-session deep-dive. Captured Q1 2026 (Apr 21) inflection — backlog $300.6M, BTB >2.0x, Roth PT $245. |
| 2026-05-29 | VICR $334.84, RSI 64.3, strong-up; +24.35% 30D, +667.28% 12M. Prior "wait for pullback to $215–$245" stance is STALE — price never pulled back, ran another +25% from May 1 $268.36. Entry zone blown through. Flag for human review to re-anchor stance. No new fundamentals re-researched. |
| 2026-06-16 | VICR $320.46, RSI 58; +11.26% 7D, +28.69% 30D, +63.23% 3M, +6.0% above SMA20 ($302.39). Pulled back from $334.84 May 29 peak; RSI cooled from 64.3 to 58 — neutral-positive, not overbought. From 52wk high -11.45%. Q2 earnings (~Jul 2026) is next anchor. Entry zone re-anchor still needed. No new fundamentals re-researched. |
| 2026-07-11 | VICR $272.05, RSI 43.3; -9.07% 7D, -8.73% 30D, +46.09% 3M, now -13.9% below SMA20 and -9.1% below SMA50, though +56.6% above SMA200 (golden cross confirmed, death cross false). From 52wk high widened to -28.9%. RSI<50 leg of the 06/16 "add on pullback with RSI<50" condition is now met, but Q2 backlog confirmation is not in this data — flagged as a tape-vs-thesis note, human review before treating as an add trigger. No new fundamentals re-researched. |
| 2026-07-17 | VICR $237.62, RSI 38.7; -12.66% 7D, -28.29% 30D, +5.7% 3M (moderated sharply), now -20.7% below SMA20 and -20.2% below SMA50, +33.0% above SMA200. From 52wk high widened to -37.9%. Price now inside the original $215-$245 entry zone; RSI<50 condition remains met, Q2-26 backlog confirmation still pending. Human review still required. No new fundamentals re-researched. |
| 2026-07-25 | VICR $211.01, RSI 36.0; -11.2% 7D, -34.53% 30D, -22.86% 3M (turned negative). Now -22.0% below SMA20 and -27.7% below SMA50, +15.3% above SMA200. From 52wk high widened to -39.53%. Price now below the original $215-$245 entry zone. RSI<50 condition remains met, Q2-26 backlog confirmation still pending. Human review still required. No new fundamentals re-researched. |
| 2026-07-28 | VICR $192.12, RSI 33; -10.52% 7D, -47.62% 30D (deepened sharply), -25.16% 3M. Now -27.1% below SMA20 and -33.6% below SMA50, cushion above SMA200 narrowed to +4.6%. From 52wk high widened to -49.79% (new deepest drawdown). Price ~7.9% above the $178 stop. RSI<50 condition remains met, Q2-26 backlog confirmation still pending. Human review still required. No new fundamentals re-researched. |
| 2026-07-31 | VICR $207.37, RSI 39.4, weak-down; 7D -1.73%; 30D -40.79%; 3M -22.73%; -45.81% from 52wk high. No new fundamentals re-researched. |
| 2026-08-08 | VICR $221.20, RSI 44.3, weak-down; 7D +6.67%; 30D -15.94%; 3M -13.75%; -42.75% from 52wk high. No new fundamentals re-researched. |
The Gold
Key Discoveries
| Discovery | Implication |
|---|---|
| Q1 2026 backlog jumped 70% in 90 days | The "curse cracking" thesis stopped being prospective — Q1 is the validation |
| Davies $200-$400/XPU is real, with 2,000-4,000A products as the basis | First concrete revenue anchor in 25 years; the framework for sizing future TAM |
| ITC enforcement = second arrow | Patent royalties from Delta + Infineon + Monolithic make the IP estate monetizable independent of socket wins |
| Insider selling at this scale ($218.8M) is heavy and warrants caution | Holders trimming a 6x in 12 months is rational, but it caps the slope of further upside near-term |
| The Razor's Edge short thesis is still useful as bear discipline | Vinciarelli-is-commercial-allergic risk has not been disproven, only delayed |
| 2026-08-14 | VICR $234.74, RSI 50.9, weak-down; 7D +6.12%; 30D -9.78%; 3M -14.23%; -40.77% from 52wk high. No new fundamentals re-researched. |
Open Questions
- Who exactly is VICR's lead Gen 5 VPD customer? "Wafer-scale AI engine" suggests Cerebras-shape, but unconfirmed publicly.
- Does the Q2 2026 print sustain $300M+ backlog or revert toward $200M?
- Will NVIDIA reference design include Vicor at any voltage layer in Rubin Ultra (2027) or Feynman (2028)?
- Is the broader Gen 4→Gen 5 transition timed for 2H 2026 actually catching second/third hyperscaler design-ins, or is the lead customer a one-off socket?
- How should the $200-$400/XPU framing pair with the actual AI XPU shipment forecasts? Is the Davies range gross opportunity or realistic capture?
- What drove the +27.84% 7D spike to $334.84 seen at May 29 refresh? Fresh catalyst or Q2 guide pre-announcement — re-research needed.
- Is the -9.07% 7D / -8.73% 30D pullback into 07/11 driven by sector-beta (whole AI-power cohort digesting) or name-specific news? Not re-researched this cycle.
Calibration Note
VICR is the most likely candidate for social-advise chorus disagreement in the AI power delivery cohort (per NuttyCLD Part 3 capture). Bulls see the inflection; bears see 25 years of "almost." Worth running through advise VICR and social-advise --ticker VICR --track for a calibrated read.
Deep-dive method: Massive (Polygon) for company/financials/short-interest/10-K, daily OHLC, technical indicators, WebSearch for Q1 2026 results + management bios + analyst targets. Cross-referenced NuttyCLD AI Power Crisis Parts 1-4 + the May 1 ai-power-delivery perspective + the May 1 full-scan brief.